SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-020614
Filing Date
2024-02-27
Accepted
2024-02-27 07:01:54
Documents
105
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apls-20231231.htm   iXBRL 10-K 3877169
2 EX-10.28 apls-ex10_28.htm EX-10.28 41833
3 EX-21.1 apls-ex21_1.htm EX-21.1 22153
4 EX-23.1 apls-ex23_1.htm EX-23.1 4262
5 EX-31.1 apls-ex31_1.htm EX-31.1 15589
6 EX-31.2 apls-ex31_2.htm EX-31.2 15599
7 EX-32.1 apls-ex32_1.htm EX-32.1 8946
8 EX-32.2 apls-ex32_2.htm EX-32.2 8708
9 EX-97.1 apls-ex97_1.htm EX-97.1 32992
10 PDF COURTESY COPY apls-ex97_1.pdf EX-97.1 114982
11 GRAPHIC img114409135_0.jpg GRAPHIC 13590
12 GRAPHIC img138179509_0.jpg GRAPHIC 26034
13 GRAPHIC img138179509_1.jpg GRAPHIC 78365
14 GRAPHIC img138179509_2.jpg GRAPHIC 55504
  Complete submission text file 0000950170-24-020614.txt   14997558

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apls-20231231.xsd EX-101.SCH 2033482
107 EXTRACTED XBRL INSTANCE DOCUMENT apls-20231231_htm.xml XML 2387783
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38276 | Film No.: 24681915
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)